BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 14523046)

  • 1. IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation.
    Alpdogan O; Muriglan SJ; Eng JM; Willis LM; Greenberg AS; Kappel BJ; van den Brink MR
    J Clin Invest; 2003 Oct; 112(7):1095-107. PubMed ID: 14523046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-21 promotes thymopoiesis recovery following hematopoietic stem cell transplantation.
    Tormo A; Khodayarian F; Cui Y; Al-Chami E; Kanjarawi R; Noé B; Wang H; Rafei M
    J Hematol Oncol; 2017 Jun; 10(1):120. PubMed ID: 28615039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
    Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation.
    Hossain MS; Roback JD; Lezhava L; Hillyer CD; Waller EK
    Biol Blood Marrow Transplant; 2005 Mar; 11(3):169-80. PubMed ID: 15744235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-transplantation of bone marrow stromal cells transduced with IL-7 gene enhances immune reconstitution after allogeneic bone marrow transplantation in mice.
    Li A; Zhang Q; Jiang J; Yuan G; Feng Y; Hao J; Li C; Gao X; Wang G; Xie S
    Gene Ther; 2006 Aug; 13(15):1178-87. PubMed ID: 16598299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation.
    Zakrzewski JL; Kochman AA; Lu SX; Terwey TH; Kim TD; Hubbard VM; Muriglan SJ; Suh D; Smith OM; Grubin J; Patel N; Chow A; Cabrera-Perez J; Radhakrishnan R; Diab A; Perales MA; Rizzuto G; Menet E; Pamer EG; Heller G; Zúñiga-Pflücker JC; Alpdogan O; van den Brink MR
    Nat Med; 2006 Sep; 12(9):1039-47. PubMed ID: 16936725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-7 drives donor T cell proliferation and can costimulate cytokine secretion after MHC-matched allogeneic bone marrow transplantation.
    Levy RB; Jones M; Hamilton BL; Paupe J; Horowitz T; Riley R
    J Immunol; 1995 Jan; 154(1):106-15. PubMed ID: 7995931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7.
    Bolotin E; Smogorzewska M; Smith S; Widmer M; Weinberg K
    Blood; 1996 Sep; 88(5):1887-94. PubMed ID: 8781449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human recombinant IL-7/HGFα hybrid cytokine enhances T-cell reconstitution in mice after syngeneic bone marrow transplantation.
    Lai L; Jin J; Hodio J; Goldschneider I
    Transplantation; 2011 Sep; 92(5):516-22. PubMed ID: 21775929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal-Derived Factor-1α and Interleukin-7 Treatment Improves Homeostatic Proliferation of Naïve CD4(+) T Cells after Allogeneic Stem Cell Transplantation.
    Gauthier SD; Leboeuf D; Manuguerra-Gagné R; Gaboury L; Guimond M
    Biol Blood Marrow Transplant; 2015 Oct; 21(10):1721-31. PubMed ID: 26151303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect on the proliferation and apoptosis of alloreactive T cells of cell dose in a murine MHC-mismatched hematopoietic cell transplantation model.
    Fujioka T; Taniguchi Y; Masuda T; Nishida S; Ikegame K; Kawakami M; Tsuboi A; Hosen N; Murakami M; Oji Y; Oka Y; Sugiyama H; Kawase I; Ogawa H
    Transpl Immunol; 2003; 11(2):187-95. PubMed ID: 12799203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymic and extrathymic differentiation and expansion of T lymphocytes following bone marrow transplantation in irradiated recipients.
    Dulude G; Brochu S; Fontaine P; Baron C; Gyger M; Roy DC; Perreault C
    Exp Hematol; 1997 Aug; 25(9):992-1004. PubMed ID: 9257813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapidly proliferating CD44hi peripheral T cells undergo apoptosis and delay posttransplantation T-cell reconstitution after allogeneic bone marrow transplantation.
    Alpdogan SO; Lu SX; Patel N; McGoldrick S; Suh D; Budak-Alpdogan T; Smith OM; Grubin J; King C; Goldberg GL; Hubbard VM; Kochman AA; van den Brink MR
    Blood; 2008 Dec; 112(12):4755-64. PubMed ID: 18815289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of interleukin-7 in the development of experimental graft-versus-host disease.
    Chung B; Dudl E; Toyama A; Barsky L; Weinberg KI
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):16-27. PubMed ID: 18158957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the spleen on compartmental levels and distribution of donor progenitor cells after syngeneic and allogeneic bone marrow transplants.
    Shatry AM; Jones M; Levy RB
    Stem Cells Dev; 2004 Feb; 13(1):51-62. PubMed ID: 15068693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell reconstitution in allogeneic haematopoietic stem cell transplantation: prognostic significance of plasma interleukin-7.
    Kielsen K; Jordan KK; Uhlving HH; Pontoppidan PL; Shamim Z; Ifversen M; Heilmann C; Nielsen CH; Sengeløv H; Ryder LP; Müller KG
    Scand J Immunol; 2015 Jan; 81(1):72-80. PubMed ID: 25263171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft-versus-host disease in allogeneic bone marrow transplantation.
    Yang J; Gao L; Liu Y; Ren Y; Xie R; Fan H; Qian K
    Transfusion; 2010 Feb; 50(2):407-17. PubMed ID: 19788510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Division rate and phenotypic differences discriminate alloreactive and nonalloreactive T cells transferred in lethally irradiated mice.
    Maury S; Salomon B; Klatzmann D; Cohen JL
    Blood; 2001 Nov; 98(10):3156-8. PubMed ID: 11698305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.